Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Agnes Ducoulombier"'
Publikováno v:
Current Opinion in Oncology. 35:166-177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::461b257bfc279df7e5e50f0c8e5c4ff3
https://doi.org/10.1097/cco.0000000000000936
https://doi.org/10.1097/cco.0000000000000936
Autor:
Fabrice Andre, Mosele Fernanda, Elise Deluche, Amelie LUSQUE, Loic Le-Bescond, Thomas Filleron, Yoann Pradat, Agnes Ducoulombier, Barbara Pistilli, Thomas Bachelot, Frederic Viret, Christelle LEVY, Nicolas Signolle, Alexia Alfaro, Diep Tran, Ingrid GARBERIS, Hugues Talbot, Stergios Christodoulidis, Maria Vakalopoulou, Nathalie Droin, Aurelie Stourm, Maki Kobayashi, Tomaya Kakegawa, Ludovic Lacroix, Patrick Saulnier, Bastien Job, Marc Deloger, Marta Jimenez, Vianney Baris, Pierre Laplante, Patricia Kannouche, Virginie Marty, Magali Lacroix-Triki, Veronique Dieras
Trastuzumab deruxtecan (T-DXd) is an anti-HER2 (human epidermal growth factor receptor 2) antibody-drug conjugate which has previously shown efficacy in patients with HER2-overexpressing and HER2-low metastatic breast cancer (mBC). However, the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff3d6f86c9dd4bce91f1964b7ce3766a
https://doi.org/10.21203/rs.3.rs-2083650/v1
https://doi.org/10.21203/rs.3.rs-2083650/v1
Autor:
Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Meeus, Sébastien Carrère, Leila Haddag-Miliani, François Le Loarer, Sylvain Causeret, Daniel Orbach, Michelle Kind, Louis-Romée Le Nail, Gwenaël Ferron, Hélène Labrosse, Loïc Chaigneau, François Bertucci, Jean-Christophe Ruzic, Valérie Le Brun Ly, Fadila Farsi, Emmanuelle Bompas, Sabine Noal, Aurore Vozy, Agnes Ducoulombier, Clément Bonnet, Sylvie Chabaud, Françoise Ducimetière, Camille Tlemsani, Mickaël Ropars, Olivier Collard, Paul Michelin, Justine Gantzer, Pascale Dubray-Longeras, Maria Rios, Pauline Soibinet, Axel Le Cesne, Florence Duffaud, Marie Karanian, François Gouin, Raphaël Tétreau, Charles Honoré, Jean-Michel Coindre, Isabelle Ray-Coquard, Sylvie Bonvalot, Jean-Yves Blay
Publikováno v:
Cancers; Volume 14; Issue 11; Pages: 2620
Cancers
Cancers, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩
Cancers
Cancers, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩
International audience; Simple Summary As patients with rare cancers face specific problems, reference networks have been developed in several European countries and then at the European level to improve their management. In some cases, the specializ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d52e3c8c77528e02fe467bfac77407c
Autor:
Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin, Astrid Lièvre, David Tougeron, Mathieu Sarabi, Marine Gilabert, Julie Wasselin, Julien Edeline, Pascal Artru, Dominique Bechade, Clémence Morin, Agnes Ducoulombier, Julien Taieb, Simon Pernot
Publikováno v:
British Journal of Cancer. 126:969-969
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4db48312ef72bd98b88da131db90462
https://doi.org/10.1038/s41416-022-01734-5
https://doi.org/10.1038/s41416-022-01734-5
Autor:
Aurelie Dumont, Emmanuelle Tresch, Jean Philippe Peyrat, Andrew Kramar, Diane Pannier, Agnes Ducoulombier, Françoise Révillion, Jinying Chen, Jacques Bonneterre
Publikováno v:
SpringerPlus
Purpose Neoadjuvant chemotherapy (NCT) using anthracyclines and taxanes is a standard treatment for locally advanced breast cancer. Efficacy of NCT is however variable among patients and predictive markers are expected to guide the selection of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e65f1f10e63ba115677d5944eb357f
https://doi.org/10.1186/s40064-015-1053-0
https://doi.org/10.1186/s40064-015-1053-0
Autor:
Aurelie Dumont, Jacques Bonneterre, Diane Pannier, Jinying Chen, Jean-Philippe Peyrat, Emmanuelle Tresch, Agnes Ducoulombier, Françoise Révillion
Publikováno v:
Journal of Clinical Oncology. 31:536-536
536 Background: Pathological complete response (pCR) is the main prognostic factor after preoperative chemotherapy. Predictive factors of pCR are mainly histological type, hormonal status, HER2 overexpression. Single nucleotide polymorphisms (SNP) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db887f3769a188eec2057ddf20d5d77
https://doi.org/10.1200/jco.2013.31.15_suppl.536
https://doi.org/10.1200/jco.2013.31.15_suppl.536
Autor:
Emmanuelle Tresch, Jinying Chen, Diane Pannier, Jacques Bonneterre, Agnes Ducoulombier, Françoise Révillion, Aurelie Dumont, Jean-Philippe Peyrat
Publikováno v:
Journal of Clinical Oncology. 31:544-544
544 Background: Neoadjuvant chemotherapy (NCT) using anthracyclines and taxanes is a standard treatment for locally advanced breast cancer and pathologic complete response (pCR) is a major prognostic factor for survival. Gene polymorphisms have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52852e9af9a4b8bb07437b163f67bb13
https://doi.org/10.1200/jco.2013.31.15_suppl.544
https://doi.org/10.1200/jco.2013.31.15_suppl.544